The Cand-Tec Candida detection system and enzyme immunoassay for serum mannan were retrospectively compared in a controlled collaborative evaluation of antigen detection in 32 patients with candidiasis proven by biopsy or culture from a normally sterile site and with sera drawn within 7 days of inclusion. With a threshold titer of 1/8, which excluded false-positive results in 17 hospitalized patients without candidiasis, sensitivities for all 32 patients with candidiasis were 44% for the Cand-Tec assay and 17% for the enzyme immunoassay. Both assays provided greater sensitivity when sera were drawn within 24 h of inclusion in the study and in the category of patients with invasive candidiasis (57% by Cand-Tec and 33% by enzyme immunoassay). The Cand-Tec assay gave false-positive results titerr, 21/8) in 4 of 6 patients with transient candidemia, in 1 of 20 otherwise healthy patients with rheumatoid factor, and in 1 patient with a positive cryptococcal latex agglutination test. Three serum specimens from 3 of 32 patients with candidiasis contained rheumatoid factor and gave titers of 21/8 by the Cand-Tec assay. Detection of serum mannan by enzyme immunoassay was less sensitive but more specific than the Cand-Tec Candida detection system for the diagnosis of invasive candidiasis.
The Cand-Tec Candida detection system and enzyme immunoassay for serum mannan were retrospectively compared in a controlled collaborative evaluation of antigen detection in 32 patients with candidiasis proven by biopsy or culture from a normally sterile site and with sera drawn within 7 days of inclusion. With a threshold titer of 1/8, which excluded false-positive results in 17 hospitalized patients without candidiasis, sensitivities for all 32 patients with candidiasis were 44% for the Cand-Tec assay and 17% for the enzyme immunoassay. Both assays provided greater sensitivity when sera were drawn within 24 h of inclusion in the study and in the category of patients with invasive candidiasis (57% by Cand-Tec and 33% by enzyme immunoassay). The Cand-Tec assay gave false-positive results titerr, 21/8) in 4 of 6 patients with transient candidemia, in 1 of 20 otherwise healthy patients with rheumatoid factor, and in 1 patient with a positive cryptococcal latex agglutination test. Three serum specimens from 3 of 32 patients with candidiasis contained rheumatoid factor and gave titers of 21/8 by the Cand-Tec assay. Detection of serum mannan by enzyme immunoassay was less sensitive but more specific than the Cand-Tec Candida detection system for the diagnosis of invasive candidiasis.
Invasive candidiasis is a frequent opportunistic infection, especially in cancer patients with neutropenia (8) . Unfortunately, diagnosis by conventional microbiological techniques is difficult. Blood cultures detect candidemia in only 35 to 44% of patients with disseminated candidiasis (17, 21) . Fungal surveillance cultures may help predict invasive candidiasis caused by Candida tropicalis, but their value for other Candida species, including C. albicans, remains uncertain (26) . Several methods have been evaluated for detecting antibodies to Candida species (5, 7) . Unfortunately, the inability of profoundly immunosuppressed patients to produce an antibody response combined with an inadequate period for antibody to reach detectable levels results in antibody tests with poor sensitivity and unsatisfactory predictive value for invasive candidiasis (5, 7). A different approach to early diagnosis of invasive candidiasis in immunocompromised patients involves the detection of circulating antigens of the Candida species (2, 5, 7, 14) . Methods have been devised for detecting the cell wall polysaccharide antigen mannan in serum by monoclonal (25) or polyclonal (6, 9) enzyme immunoassay (EIA), radioimmunoassay (23, 29) , latex agglutination (1, 12, 15) , or coagglutination (16); detecting a 48-kilodalton cytoplasmic protein antigen by monoclonal EIA (19, 27, 28) or dot immunoassay (18) ; and detecting a heat-labile glycoprotein antigen by latex agglutination (1, 3, 10, 11, 15, 22, 24) . The latter method is commercially available as the Cand-Tec Candida detection system (11, 24) , but the assay appears to be insensitive (19 to 71%) (1, 3, 10, 11, 15, 22, 24) with a titer of 1/8, which excludes most false-positive results. This lack of sensitivity is especially frequent on single serum specimens (3, 15) . The * Corresponding author.
Cand-Tec test was compared with a latex agglutination method for serum mannan in two studies (1, 15) , and the mannan test was found to have greater sensitivity and equivalent specificity for invasive candidiasis. We previously reported a retrospective evaluation of the doubleantibody sandwich EIA for serum mannan in cancer patients with or without invasive candidiasis, which demonstrated a sensitivity of 65% and a specificity of 100% (6) . In the present study, the Cand-Tec test and EIA for serum mannan were compared in a controlled collaborative evaluation of their predictive value in the diagnosis of invasive candidiasis. Table 3 . Both assays provided greater sensitivity when sera were drawn within 24 h of inclusion in the study and in the category of patients with invasive candidiasis (57% by Cand-Tec and 33% by EIA).
MATERIALS AND METHODS
Eighteen of 26 patients infected with C. albicans had a Cand-Tec titer of .1/4 (1/4 titer, 6 patients; .1/8 titer, 12 patients). Sera from three of the 18 patients, however, contained rheumatoid factor and were negative in the mannan EIA. Four of 26 patients infected with C. albicans had detectable serum mannan (.2 ng/ml, three patients; <2 ng/ml, one patient).
Antigen was detected by both assays in two patients infected with C. tropicalis. The two patients infected with C. paratropicalis and the two patients infected with C. krusei, however, had negative results by Cand-Tec and EIA.
Three sera from three patients (one with transient candidemia and two with sustained candidemia; Table 2) contained rheumatoid factor and gave titers of 1/8 to 1/32 by the Cand-Tec assay. If these sera were withdrawn from analysis, sensitivities at a titer of 1/8 (Table 3) decreased from 44 to 34% for all patients with candidiasis, from 24 to 21% for all sera, from 34 to 29% for sera drawn within 7 days of inclusion, and from 44 to 36% for sera drawn within 24 h of inclusion in the study.
DISCUSSION
The clinical and microbiological diagnosis of invasive candidiasis is difficult. One approach to early diagnosis involves the detection of circulating antigens of Candida species. In candidiasis, methods have been devised for detecting the cell wall polysaccharide antigen mannan in serum by monoclonal (25) or polyclonal (6, 9) EIA, radioim-VOL. 28, 1990 on October munoassay (23, 29) , latex agglutination (1, 12, 15) , or coagglutination (16) ; detecting a 48-kilodalton cytoplasmic protein antigen by monoclonal EIA (19, 27, 28) or dot immunoassay (18) ; and detecting a heat-labile glycoprotein antigen by commercial Cand-Tec agglutination (1, 3, 10, 11, 15, 22, 24 (20) . Sera from normal blood donors were not assayed for mannan because it was previously shown that the antigen is uniformly undetectable by EIA in this control population (6) . The sensitivity of the EIA for serum mannan in patients with proven invasive candidiasis (23%) was lower than that observed in a previous study (65%) (6) with identical reagents. The mean number of serum samples tested per patient, however, was greater in the previous (7.5) than in the present (3.0) study, and this difference can affect sensitivity data because the presence of antigen in serum is often transient (6, 15) . In addition, patients in the present study were not as profoundly immunosuppressed as those in the previous evaluation. The degree of immunosuppression of these populations may influence the production of antibodies to mannan and consequently the clearance of circulating antigen. The proximity of serum collection to the time of diagnosis can also influence diagnostic sensitivity, especially if antigenemia is not sustained but transient. Both the Cand-Tec assay and the EIA for serum mannan produced greater sensitivities in sera drawn within 24 h of inclusion in the study. This observation suggests that optimal diagnostic sensitivity would require at least weekly serum samplings.
The results of this study agree with published clinical evaluations (1, 3, 10, 11, 15, 22, 24) of the Cand-Tec test. These demonstrated that a titer of 1/8 is usually diagnostic of invasive candidiasis, whereas a titer of 1/4 occurs more commonly in invasive disease but is also found in control patients without candidiasis. However, titers of 21/8 were observed not only in patients with invasive candidiasis but also in 66% of patients with transient candidemia. The EIA for serum mannan was more specific, and antigen (22 ng/ml) was not detected in patients with transient candidemia. The Cand-Tec kit does not contain control latex sensitized with normal rabbit serum, and thus false-positive results due to rheumatoid factor were observed, as in previous reports (3) . Since the antigen detected by the Cand-Tec assay has not been definitely characterized as a component of the fungus, it is not known whether it contains shared epitopes with cryptococcal capsular polysaccharide. The sensitivity of the antigen to heat and the inability of sensitized latex to agglutinate mannan (11) suggest that the circulating CandTec antigen is not mannan.
In previous reports, the Cand-Tec test (1, 3, 11, 15) and EIA for serum mannan (6) detected antigenemia in patients infected with C. albicans, C. parapsilosis, or C. tropicalis. Both methods appeared to be insensitive in patients infected with C. krusei, C. parapsilosis, or C. paratropicalis, but the numbers were too small to draw firm conclusions.
The moderate sensitivities of the Cand-Tec assay and EIA for serum mannan do not provide optimum negative predictive value for invasive candidiasis. The high specificity ofthe EIA for serum mannan, however, suggests that the presence of this circulating antigen in patients at risk is closely correlated with visceral candidal infection.
